SFA
FRTX

Sequoia Financial Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Sequoia Financial Advisors’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-223
Closed -$10K – 477
2021
Q2 		$10K Hold
223
– – ﹤0.01% 477
2021
Q1 		$11K Hold
223
– – ﹤0.01% 445
2020
Q4 		$8K Buy
+223
New +$7K ﹤0.01% 417

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sequoia Financial Advisors's FRTX Position: Q3 2021 in Review

Sequoia Financial Advisors sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2021, closing a stake of 223 shares — an estimated $10K sold.

Sequoia Financial Advisors first reported a position in FRTX in Q4 2020 and held it in 3 quarters. The position peaked at $11K in Q1 2021. 27 funds tracked by Wall St. Rank hold FRTX as of Q3 2021.

  • Sequoia Financial Advisors reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Sequoia Financial Advisors sold 223 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $10K.
  • Sequoia Financial Advisors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Sequoia Financial Advisors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $11K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Sequoia Financial Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.